Canadian Securities Exchange

C3 Pharmaceuticals Announces IPO Plans On Canadian Exchange, Funding For Cannabis Tablet As SEC Battle Continues
Tryp Therapeutics Set To Finalize Merger With Exopharm, Announces Trading Halt Ahead Of ASX Listing
Sacred Medicine Meets Wall Street: Legal Peyote Company Will Trade On Canadian Market
Tryp Therapeutics Set To Finalize Merger With Exopharm, Announces Trading Halt Ahead Of ASX Listing
Sacred Medicine Meets Wall Street: Legal Peyote Company Will Trade On Canadian Market
TerrAscend Receives Conditional Approval To List On Toronto Stock Exchange
Oregon Marijuana Giant Files For Creditor Protection, Seeks Buyer To Keep Creditors At Bay

Canadian Securities Exchange Recent News

Another Ketamine Therapy Company Goes Public: Optimind Pharma Is Now "OMND" On The CSE
Medical cannabis and alternative medicines provider Optimind Pharma Corp. began trading on the Canadian Securities Exchange (CSE) under the ticker symbol "OMND".
EXCLUSIVE: How Are Cannabis Companies Navigating The Current Capital Dry Spell?
Raising capital in the current market is proving to be increasingly challenging for cannabis companies today.
Albert Labs, Psychedelic Biotech Company Shares Now Available On Canadian Exchange
Albert Labs, a British-Columbia based biotech company, announced Thursday that it closed its private placement and that its shares will begin trading on the Canadian Securities Exchange (CSE). Albert Labs will trade under the ticker symbol “ABRT.” 
The Green Organic Dutchman To Debut On CSE, Poised To Enter U.S. Cannabis Market
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) disclosed Thursday its intentions to list its common shares and listed common share purchase warrants on the Canadian Securities Exchange.
Meet MGO/ELLO's 'Cannabis 50' Honorees, From Jim Belushi To Flow Kana
4 Observations From The First Ever 'Cannabis Investor Day'
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The uncertain regulatory environment in the U.S. has not stopped the cannabis industry from putting down roots in the secondary market.
Sponsored
Previewing The First Ever 'Cannabis Investor Day'
Cannabis Company Avicanna Eyes Canadian IPO

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved